Greenway Schond L. insider trades
Greenway Schond L. has filed 9 Form 4s with the SEC that we hold, for Definium Therapeutics, Inc. (MNMD) (Chief Financial Officer) and Avalo Therapeutics, Inc. (AVTX) (CFO). Across all of them we count 1 purchase worth $3.5K and 6 sales worth $154.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 20,000 shares of Definium Therapeutics, Inc. worth $76.0K, dated 2023-08-25. The first filing on our record is dated 2021-12-14 and the latest 2024-03-26.
Definium Therapeutics, Inc. (MNMD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-27 | S, sale reported on Form 4 | 7,694 | $24.5K | 2023-06-27 |
| 2023-06-27 | S, sale reported on Form 4 | 3,941 | $12.7K | 2023-06-27 |
| 2023-08-25 | S, sale reported on Form 4 | 20,000 | $76.0K | 2023-08-28 |
| 2023-09-25 | S, sale reported on Form 4 | 3,854 | $13.8K | 2023-09-25 |
| 2023-09-25 | S, sale reported on Form 4 | 1,908 | $6.8K | 2023-09-25 |
| 2023-12-26 | S, sale reported on Form 4 | 5,652 | $20.5K | 2023-12-26 |
Avalo Therapeutics, Inc. (AVTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-10 | P, purchase reported on Form 4 | 2,231 | $3.5K | 2021-12-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1848205) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms